The smoking cessation efficacy of bupropion hydrochloride sustained release tablets (BUP SR) versus placebo (PBO) in smokers with chronic obstructive pulmonary disease (COPD) with respect to age, gender, pack-year history and COPD D. P. Tashkin, R. E. Kanner, W. C. Bailey, S. A. Buist, P. J. Anderson, G. Dozier, B. D. Jamerson, M. K. Patel (Los Angeles, Salt Lake City, Birmingham, Portland, Little Rock, Research Triangle Park, United States Of America)
Source: Annual Congress 2001 - Smoking cessation: COPD patients
Session: Smoking cessation: COPD patients Session type: Oral PresentationNumber: 1365
Disease area: Airway diseasesRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. P. Tashkin, R. E. Kanner, W. C. Bailey, S. A. Buist, P. J. Anderson, G. Dozier, B. D. Jamerson, M. K. Patel (Los Angeles, Salt Lake City, Birmingham, Portland, Little Rock, Research Triangle Park, United States Of America). The smoking cessation efficacy of bupropion hydrochloride sustained release tablets (BUP SR) versus placebo (PBO) in smokers with chronic obstructive pulmonary disease (COPD) with respect to age, gender, pack-year history and COPD. Eur Respir J 2001; 16: Suppl. 31, 1365
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
COPD patients‘ response to smoking cessation Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005
Smoking cessation and COPD Source: Eur Respir Rev 2013; 22: 37-43 Year: 2013
The effect of bupropion on smoking cessation and sleep physiology in COPD and asthma patients Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations Year: 2018
Introductory lecture: Nicotine addiction treatment in COPD patients Source: Annual Congress 2007 - Smoking and COPD Year: 2007
Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in smokers with cardiovascular disease. 12 month follow-up phase data (ZYB40014) Source: Eur Respir J 2002; 20: Suppl. 38, 611s Year: 2002
Recommendations for smoking cessation treatment in respiratory patients Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients Year: 2007
Bupropion hydrochloride sustained release (SR) is an effective and well tolerated aid to smoking cessation in smokers with cardiovascular disease - a multicountry study Source: Eur Respir J 2001; 18: Suppl. 33, 12s Year: 2001
Smoking cessation in COPD patients (with comorbidities) Source: International Congress 2017 – PG14 Smoking cessation in patients with respiratory diseases Year: 2017
The SMOKE study: 1 year evaluation of an intensive multi-component smoking cessation programme for COPD outpatients Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005
Effects of smoking cessation in COPD Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke? Year: 2006
Effectiveness of a smoking cessation programme for COPD (SMOCC) in routine general practice Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005
The efficacy of formoterol in patients with chronic obstructive pulmonary disease (COPD) is not influenced by concomitant corticosteroid use Source: Eur Respir J 2001; 18: Suppl. 33, 515s Year: 2001
Salmeterol, added to usual therapy, is an effective bronchodilator over 12 months of treatment in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 241s Year: 2002
Effect of 1-year smoking cessation on matrix-metalloproteinases and their inhibitors in COPD Source: Annual Congress 2006 - Cell biology of asthma and COPD Year: 2006
Success of smoking cessation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results Year: 2005
Developing COPD – a 25 year follow-up study of the general population Source: Annual Congress 2005 - Better understanding of lung function decline and COPD Year: 2005
Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004
LATE-BREAKING ABSTRACT: Effects of a fixed dose once-daily triple drug combination in smokers and non-smokers with COPD Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
Smoking cessation and prevention Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=242 Year: 2006
Detection of spirometrically-defined COPD in a population of smokers referred to a smoking cessation clinic Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006